Please use this identifier to cite or link to this item:
Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014
|TCA Midyear Poster 2016 PDF_So_Taira.pdf||3.87 MB||Adobe PDF||View/Open|
|Title:||Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014|
|Authors:||So, Nadine W.|
|Keywords:||Antidepressive Agents, Tricyclic|
Medicare Part D
Physicians' practice patterns
|Date Issued:||11 Apr 2017|
|Abstract:||Tricyclic antidepressants were the primary pharmacologic treatment for depression in the United States from the 1960s to the late 1980s. Since then, other classes of antidepressants, such as Selective Serotonin Reuptake Inhibitors, have replaced its use as first-line agents due to their more favorable side-effect profile and proven equal efficacy. Tricyclic antidepressants are included in the Beers Criteria because of their potentially harmful side effects in the elderly (e.g. cognitive impairment, delirium, sedation, and orthostatic hypotension). The purpose of this study is to evaluate the changes in prescribing
of tricyclic antidepressants from 2013 to 2014 in Medicare beneficiaries.
|Rights:||This item is licensed under a Creative Commons License.|
|Appears in Collections:||
DKICP Student Research Projects|
Please email firstname.lastname@example.org if you need this content in ADA-compliant format.
This item is licensed under a Creative Commons License